Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
$9.2MCash on Hand
2mo Cash Runway
Follow TXMD by emailGet an email when TXMD pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.
We send one confirmation email first. Only emails about TXMD, unsubscribe in one click. Privacy
🧪 Trial & FDA Catalysts
Jun 2021 · Phase 1 · Results Expected · The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetat Registry primary completion date, not a results date
Jan 2021 · Phase 1 · Results Expected · Annovera™ Drug-Drug Interaction Study Registry primary completion date, not a results date
Oct 2016 · Phase 3 · Results Expected · A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomot Registry primary completion date, not a results date
Oct 2015 · Phase 3 · Results Expected · Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in P Registry primary completion date, not a results date
Sep 2013 · Phase 2 · Results Expected · TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms Registry primary completion date, not a results date
Also used in these trials (approved or third-party drugs, not TXMD's own candidates): Estradiol, Progesterone, Itraconazole, Rifampin.
Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it
💰 Cash Runway & Dilution Risk
TXMD holds $9.2M in cash and short-term investments (as of Jun 30, 2026) and burns about $13.8M/quarter from operations,
an estimated runway of 2 months at that rate (BioRadar estimate, not company guidance).
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for TXMD and every other ticker you follow. Card required, cancel anytime.
Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.